Tirap controls Mycobacterium tuberculosis phagosomal acidification

PLoS Pathog. 2023 Mar 8;19(3):e1011192. doi: 10.1371/journal.ppat.1011192. eCollection 2023 Mar.

Abstract

Progression of tuberculosis is tightly linked to a disordered immune balance, resulting in inability of the host to restrict intracellular bacterial replication and its subsequent dissemination. The immune response is mainly characterized by an orchestrated recruitment of inflammatory cells secreting cytokines. This response results from the activation of innate immunity receptors that trigger downstream intracellular signaling pathways involving adaptor proteins such as the TIR-containing adaptor protein (Tirap). In humans, resistance to tuberculosis is associated with a loss-of-function in Tirap. Here, we explore how genetic deficiency in Tirap impacts resistance to Mycobacterium tuberculosis (Mtb) infection in a mouse model and ex vivo. Interestingly, compared to wild type littermates, Tirap heterozygous mice were more resistant to Mtb infection. Upon investigation at the cellular level, we observed that mycobacteria were not able to replicate in Tirap-deficient macrophages compared to wild type counterparts. We next showed that Mtb infection induced Tirap expression which prevented phagosomal acidification and rupture. We further demonstrate that the Tirap-mediated anti-tuberculosis effect occurs through a Cish-dependent signaling pathway. Our findings provide new molecular evidence about how Mtb manipulates innate immune signaling to enable intracellular replication and survival of the pathogen, thus paving the way for host-directed approaches to treat tuberculosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • Animals
  • Humans
  • Hydrogen-Ion Concentration
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mycobacterium tuberculosis*
  • Receptors, Interleukin-1 / genetics
  • Receptors, Interleukin-1 / metabolism
  • Signal Transduction
  • Tuberculosis*

Substances

  • Receptors, Interleukin-1
  • Adaptor Proteins, Signal Transducing
  • TIRAP protein, human
  • Membrane Glycoproteins
  • TIRAP protein, mouse

Grants and funding

Financial support for this work was provided by the Agence Nationale de la Recherche (n°ANR-16-CE35-0009 and ANR-18-JAM2-0002 to PB), the EMBO Young Investigator Program (to PB), the Feder (n°12001407 (D-AL) Equipex Imaginex BioMed to PB), the I-SITE ULNE Foundation (ERC Generator Grant to EH) and the Fondation pour la Recherche Medicale (n°SPF20170938709 to AM). Parts of this project were also supported under the framework of the JPIAMR – Joint Programming Initiative on Anti-microbial Resistance 2018-00969 (to PB, AM and JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.